Upregulation of TLR4/MyD88 pathway in alcohol-induced Wernicke's encephalopathy: Findings in preclinical models and in a postmortem human case.

Wernicke–Korsakoff syndrome alcohol use disorder (AUD) cerebellum frontal cortex neuroinflammation thiamine deficiency

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2022
Historique:
received: 31 01 2022
accepted: 29 07 2022
entrez: 13 10 2022
pubmed: 14 10 2022
medline: 14 10 2022
Statut: epublish

Résumé

Wernicke's encephalopathy (WE) is a neurologic disease caused by vitamin B1 or thiamine deficiency (TD), being the alcohol use disorder its main risk factor. WE patients present limiting motor, cognitive, and emotional alterations related to a selective cerebral vulnerability. Neuroinflammation has been proposed to be one of the phenomena that contribute to brain damage. Our previous studies provide evidence for the involvement of the innate immune receptor Toll-like (TLR)4 in the inflammatory response induced in the frontal cortex and cerebellum in TD animal models (animals fed with TD diet [TDD] and receiving pyrithiamine). Nevertheless, the effects of the combination of chronic alcohol consumption and TD on TLR4 and their specific contribution to the pathogenesis of WE are currently unknown. In addition, no studies on TLR4 have been conducted on WE patients since brains from these patients are difficult to achieve. Here, we used rat models of chronic alcohol (CA; 9 months of forced consumption of 20% (w/v) alcohol), TD hit (TDD + daily 0.25 mg/kg i.p. pyrithiamine during 12 days), or combined treatment (CA + TDD) to check the activation of the proinflammatory TLR4/MyD88 pathway and related markers in the frontal cortex and the cerebellum. In addition, we characterized for the first time the TLR4 and its coreceptor MyD88 signature, along with other markers of this proinflammatory signaling such as phospo-NFκB p65 and IκBα, in the postmortem human frontal cortex and cerebellum (gray and white matter) of an alcohol-induced WE patient, comparing it with negative (no disease) and positive (aged brain with Alzheimer's disease) control subjects for neuroinflammation. We found an increase in the cortical TLR4 and its adaptor molecule MyD88, together with an upregulation of the proinflammatory signaling molecules p-NF-ĸB and IĸBα in the CA + TDD animal model. In the patient diagnosed with alcohol-induced WE, we observed cortical and cerebellar upregulation of the TLR4/MyD88 pathway. Hence, our findings provide evidence, both in the animal model and the human postmortem brain, of the upregulation of the TLR4/MyD88 proinflammatory pathway in alcohol consumption-related WE.

Identifiants

pubmed: 36225571
doi: 10.3389/fphar.2022.866574
pii: 866574
pmc: PMC9549119
doi:

Types de publication

Journal Article

Langues

eng

Pagination

866574

Informations de copyright

Copyright © 2022 Moya, Escudero, Gómez-Blázquez, Rebolledo-Poves, López-Gallardo, Guerrero, Marco and Orio.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
Neurochem Int. 2010 Nov;57(5):556-64
pubmed: 20637248
Mol Neurobiol. 2016 Apr;53(3):2016-2028
pubmed: 25862375
AJNR Am J Neuroradiol. 2016 Jun;37(6):1005-9
pubmed: 26939633
Biomed Res Int. 2019 Jul 18;2019:7420189
pubmed: 31396533
Front Neurosci. 2020 Dec 18;14:602508
pubmed: 33390886
Psychol Med. 1990 Feb;20(1):63-75
pubmed: 2320699
Neuroimage. 2001 Jun;13(6 Pt 1):1164-73
pubmed: 11352622
Behav Neurol. 2001-2002;13(3-4):89-94
pubmed: 12446948
J Cogn Neurosci. 1997 Mar;9(2):277-93
pubmed: 23962017
Acta Neuropathol. 2014 Jan;127(1):71-90
pubmed: 24370929
Front Mol Neurosci. 2019 Jan 09;11:490
pubmed: 30687006
J Neuroinflammation. 2018 Sep 4;15(1):251
pubmed: 30180869
Am J Clin Nutr. 1980 Dec;33(12):2719-26
pubmed: 6108071
Biol Psychiatry. 2013 Apr 1;73(7):602-12
pubmed: 23206318
Neuroscience. 1997 Aug;79(4):983-98
pubmed: 9219961
PLoS One. 2015 Oct 13;10(10):e0140311
pubmed: 26461913
J Neurol Neurosurg Psychiatry. 1979 Mar;42(3):226-31
pubmed: 438830
Alcohol Clin Exp Res. 2019 Mar;43(3):425-438
pubmed: 30589435
Cerebellum. 2006;5(1):55-63
pubmed: 16527765
Expert Opin Ther Targets. 2019 Oct;23(10):865-882
pubmed: 31580163
Cogn Affect Behav Neurosci. 2008 Dec;8(4):485-97
pubmed: 19033243
Nutr Hosp. 2018 Apr 05;35(3):564-569
pubmed: 29974763
Glia. 2012 May;60(6):948-64
pubmed: 22431236
Biomolecules. 2020 May 26;10(6):
pubmed: 32466476
Brain Behav Immun. 2011 Jun;25 Suppl 1:S80-91
pubmed: 21352907
Cortex. 2011 Jan;47(1):137-44
pubmed: 19786276
Ann N Y Acad Sci. 2016 Mar;1367(1):21-30
pubmed: 26971083
Biomed Res Int. 2014;2014:503596
pubmed: 25050351
Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):481-492
pubmed: 28803924
Pathol Res Pract. 2011 Oct 15;207(10):652-8
pubmed: 21930349
World J Gastroenterol. 2018 Dec 7;24(45):5063-5075
pubmed: 30568384
Front Aging Neurosci. 2018 Nov 27;10:396
pubmed: 30542279
J Alzheimers Dis. 2018;63(4):1547-1556
pubmed: 29782315
Ann Clin Biochem. 2021 Jan;58(1):38-46
pubmed: 32551830
Bio Protoc. 2019 Dec 20;9(24):
pubmed: 31867411
Brain Res. 2016 Sep 1;1646:62-72
pubmed: 27208497
Cell Mol Life Sci. 2021 Feb;78(4):1233-1261
pubmed: 33057840
Physiol Behav. 2015 Sep 1;148:131-44
pubmed: 25708278
Hepatol Int. 2018 Feb;12(Suppl 1):135-147
pubmed: 28770516
Int J Neurosci. 2017 Jul;127(7):624-633
pubmed: 27412492
Int J Mol Sci. 2022 Jan 11;23(2):
pubmed: 35054960
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jun 8;108:110190
pubmed: 33271211
Front Pharmacol. 2021 Sep 24;12:716684
pubmed: 34630095
Gastroenterol Rep (Oxf). 2017 May;5(2):138-147
pubmed: 28533911
World J Hepatol. 2020 Jul 27;12(7):332-349
pubmed: 32821333
Neurosci Biobehav Rev. 2016 May;64:134-47
pubmed: 26905767
Drugs. 2019 Feb;79(Suppl 1):5-9
pubmed: 30706420
BMC Cancer. 2011 Jun 25;11:271
pubmed: 21702992
J Leukoc Biol. 2019 Jul;106(1):147-160
pubmed: 30900780
J Neuroimmunol. 2019 Jul 15;332:16-30
pubmed: 30928868
Front Immunol. 2022 Mar 03;13:812774
pubmed: 35309296
J Hepatol. 2020 Aug;73(2):423-440
pubmed: 32330604
Alcohol Clin Exp Res. 2016 Nov;40(11):2260-2270
pubmed: 27650785
Addict Biol. 2017 May;22(3):724-741
pubmed: 26857094
World J Hepatol. 2015 Jun 28;7(12):1701-7
pubmed: 26140090
Drug Alcohol Depend. 2022 Jan 1;230:109186
pubmed: 34864357
Cerebellum. 2016 Jun;15(3):369-91
pubmed: 26105056
Neuropsychopharmacology. 1991 May;4(3):175-86
pubmed: 2064717
Cerebellum. 2008;7(4):611-5
pubmed: 18941861
Gastroenterology. 2003 Dec;125(6):1834-44
pubmed: 14724835
Clin Neurol Neurosurg. 2008 Sep;110(8):763-73
pubmed: 18602745
Pharmacol Ther. 2021 Dec;228:107918
pubmed: 34171331
Br J Psychiatry. 1995 Feb;166(2):154-73
pubmed: 7728359
Liver Int. 2021 Jul;41(7):1474-1488
pubmed: 33900013
Alcohol Alcohol. 2009 Mar-Apr;44(2):136-40
pubmed: 19147798
Front Syst Neurosci. 2021 Apr 09;15:646052
pubmed: 33897383
Int J Neuropsychopharmacol. 2014 Dec 28;18(6):
pubmed: 25548106
Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1247-52
pubmed: 9448317
Neurosci Lett. 1996 Aug 16;214(1):33-6
pubmed: 8873125
Rev Clin Esp. 2011 Oct;211(9):458-63
pubmed: 21890127
Front Immunol. 2014 Jul 10;5:316
pubmed: 25071777
J Neurol Sci. 2012 Apr 15;315(1-2):67-71
pubmed: 22166855
Rev Gastroenterol Mex. 2014 Apr-Jun;79(2):135-44
pubmed: 24861526
Front Immunol. 2020 Aug 26;11:1588
pubmed: 32983082
Exp Neurol. 2014 Nov;261:109-19
pubmed: 24973622
Neuropsychol Rev. 2012 Jun;22(2):170-80
pubmed: 22577003
Biomedicines. 2022 Jan 25;10(2):
pubmed: 35203470
Trends Biochem Sci. 2012 Mar;37(3):92-8
pubmed: 22196451
Alcohol Clin Exp Res. 2020 Dec;44(12):2481-2493
pubmed: 33067870
Medicine (Baltimore). 2016 Jul;95(27):e3651
pubmed: 27399058
F1000Res. 2017 Sep 4;6:1637
pubmed: 29026534
Alcohol Alcohol. 2017 May 01;52(3):305-310
pubmed: 28007738
Mol Psychiatry. 2008 May;13(5):480-97
pubmed: 18180766
Front Cell Neurosci. 2018 Oct 02;12:329
pubmed: 30333729
Brain. 2011 Apr;134(Pt 4):1015-32
pubmed: 21414994
Lab Invest. 2018 Jul;98(7):844-855
pubmed: 29849125
J Inflamm Res. 2018 Oct 30;11:407-419
pubmed: 30464573
J Clin Invest. 2018 Oct 1;128(10):4297-4312
pubmed: 29990310
Neuropsychiatr Dis Treat. 2017 Nov 27;13:2875-2890
pubmed: 29225466
Biomolecules. 2018 Jan 13;8(1):
pubmed: 29342874

Auteurs

Marta Moya (M)

Department of Psychobiology and Methods in Behavioral Science, Faculty of Psychology, Complutense University of Madrid, Madrid, Spain.

Berta Escudero (B)

Department of Psychobiology and Methods in Behavioral Science, Faculty of Psychology, Complutense University of Madrid, Madrid, Spain.

Elena Gómez-Blázquez (E)

Biobanco of Hospital Universitario Fundación Alcorcón, Alcorcón, Spain.

Ana Belen Rebolledo-Poves (AB)

Biobanco of Hospital Universitario Fundación Alcorcón, Alcorcón, Spain.

Meritxell López-Gallardo (M)

Department of Physiology, Faculty of Medicine, Complutense University of Madrid, Madrid, Spain.

Carmen Guerrero (C)

Biobanco of Hospital Universitario Fundación Alcorcón, Alcorcón, Spain.

Eva M Marco (EM)

Department of Genetics, Physiology and Microbiology, Faculty of Biology, Complutense University of Madrid, Madrid, Spain.

Laura Orio (L)

Department of Psychobiology and Methods in Behavioral Science, Faculty of Psychology, Complutense University of Madrid, Madrid, Spain.
Research Network in Primary Care in Addictions (Red de Investigación en Atención Primaria en Adicciones), Riapad, Spain.

Classifications MeSH